Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP18 inhibits Neoplasm Invasiveness. 4 / 4

| 4

➶

reach

"Functionally, decreased USP18 expression attenuated GBM cell invasion and migration through repressing EMT."

32368392

➶

reach

"USP18 knock-down reduced lung cancer growth, wound-healing, migration, and invasion versus controls (P < .001) and markedly decreased murine lung cancer metastases (P < .001)."

35387560

➶

reach

"Furthermore, cell apoptosis was promoted by USP18 silencing, and interference of USP18 suppressed cell migration and invasion."

35696596

➶

reach

"Lack of Usp18 inhibits angiogenesis and reduces invasiveness of mammary epithelial tumour cells."

23681607

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

USP18 inhibits Neoplasm Invasiveness. 4 / 4

Our Sources:

Databases

Reading